Seguimiento Farmacoterapéutico en pacientes con Diabetes Mellitus Tipo II del Subcentro de Salud Guano-Chimborazo

Abstract

The aim of this work was to carry out a pharmacotherapeutic follow-up in type II diabetes mellitus patients who attend to Subcentro de Salud Guano-Chimborazo, applying the Dáder Method as strategies to identify Medication-Related Problems (MRPs) and Negative Results Associated with Medication (NRM) through pharmaceutical interventions, and using the Morisky-Green- Levine Test, in order to measure adherence to pharmacological treatment. For this research, there were 25 patients, 19 were female and 6 were male, aged 30-85 years, showing 56 (NRM); 54% effectiveness, 34% need and 18% safety. There was recurrent non-adherence to treatment and drug interactions between hypoglycemic, antihypertensive, thyroid hormones and medicinal plants, where the Morisky-Green-Levine test was applied, showing that at the beginning 80% of the patients were not adherent while at the end 84% of adherence to pharmacological treatment was obtained. The results before the intervention were: glucose 188.28 mg/dL, glycosylated hemoglobin (HbA1c) 8.98%, cholesterol 217.08 mg/dL, triglycerides 153.2 mg/dL, BMI 27.85 kg/m2, and at the end glucose was 143.16 mg/dL, HbA1c 6.98%, cholesterol 182 mg/dL, triglycerides 126.12 mg/dL, BMI 27.15 kg/m2. It is concluded that the Pharmacotherapeutic follow-up is effective and safe because it has a positive impact on improving adherence to treatment, control of clinical parameters of type II diabetes mellitus, improving patient’s quality of life. It is suggested that health team be encouraged to work with the medical staff, nutritionists, psychologists and pharmacists, so that patients can address all their concerns about the different pathologies and medical treatment.